New EUR 18 million financing aimed at accelerating the development in connected health, particularly in the USA

VISIOMED GROUP (FR0011067669 – ALVMG), company specialized in new generation medical electronic, announcestoday the implementation of a new financing through the issuance of convertible notes with share subscription warrants attached (Notes With Warrants) allowing a maximum potential fundraising of EUR 18 million. This issuance, fully subscribed by a fund managed by investment manager L1 Capital, aims at financing the Group’s development in connected health and in particular its deployment in the USA.